Zai Lab - Stock Price History | ZLAB

Historical daily share price chart and data for Zai Lab since 2023 adjusted for splits. The latest closing stock price for Zai Lab as of February 03, 2023 is 40.09.
  • The all-time high Zai Lab stock closing price was 191.71 on January 20, 2021.
  • The Zai Lab 52-week high stock price is 61.29, which is 52.9% above the current share price.
  • The Zai Lab 52-week low stock price is 20.98, which is 47.7% below the current share price.
  • The average Zai Lab stock price for the last 52 weeks is 38.56.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Zai Lab Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 39.4787 64.4000 64.4000 22.2800 30.7000 -51.15%
2021 135.6899 129.7800 191.7100 54.9000 62.8500 -53.56%
2020 75.6760 42.6200 135.3400 39.1000 135.3400 225.41%
2019 32.0775 22.3000 43.0600 21.7100 41.5900 79.11%
2018 21.1106 22.2600 26.9600 14.9500 23.2200 9.37%
2017 26.7446 27.9300 34.0900 21.2300 21.2300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.925B $0.144B
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00